Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 3, 2013
Grant Date -
Jan 6, 2011
app pub date -
Mar 26, 2010
filing date -
Oct 21, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a conjugate that contains a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of pre-malignant dysplastic skin and which includes the amino acid sequence SRPRR (SEQ ID NO: 1) or a conservative variant or peptidomimetic thereof. The present invention further provides a conjugate containing a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of malignant skin and which includes the amino acid sequence CGKRK (SEQ ID NO: 6) or the amino acid sequence CDTRL (SEQ ID NO: 7), or a conservative variant or peptidomimetic of one of these sequences.
First Claim
Other Claims data not available
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 3, 2025 |
